Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dividend Aristocrats Part 18 of 52: AFLAC Incorporated (AFL)

Page 1 of 3
AFLAC Incorporated (NYSE:AFL) is the global leader in cancer insurance. The company sells supplemental life, health, and accident insurance.
Elite hedge funds tracked by Insider Monkey held just 2.00% of Aflac’s outstanding shares, though they were collectively becoming more bullish on the stock in the second quarter. Investors in our database which were long Aflac rose to 27 from 22, though the value of their stakes did decline by about $56 million during that time, to $548 million. Peter Muller’s PDT Partners was one of the investors that went long on Aflac in the second quarter, purchasing just over 104,000 shares.

Aflac generates about 75% of its premium revenue in Japan. The remaining 25% of premium revenue comes from the United States.

Up to this point many of my Dividend Aristocrat reports have ended disappointingly. Most of the 17 Dividend Aristocrats analyzed up to this point have been ‘holds’, not ‘buys’.


This analysis is different.  Aflac is a buy at current prices. I am currently long Aflac. This article will answer the following questions about Aflac:

  • Is the insurance industry stable enough for long-term investors?
  • How will Japan’s struggling economy affect Aflac?
  • Does Aflac have favorable growth prospects?
  • Does Aflac have a shareholder friendly management?
  • What are Aflac’s expected total returns?
  • How does Aflac perform during recessions?
  • Is Aflac stock currently undervalued?

Is the insurance industry stable enough for long-term investors?

The insurance industry is responsible for several phenomenal fortunes.

Warren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK.A) is the largest insurer in the world. The lesser known Shelby Davis made $900 million investing in insurance companies (including Aflac). Even hedge fund manager David Einhorn has entered the insurance industry with Greenlight Capital Re, Ltd. (NASDAQ:GLRE).

The insurance industry has two primary characteristics that make it suitable for compounding wealth.

  1. The insurance industry is extremely stable
  2. The insurance industry gives investors a negative cost of capital

Insurance has not changed too much since Lloyd’s of London began selling marine insurance in the 17th century.  Insurance uses the ‘law of large numbers’ to spread the risk of a negative event (like a car wreck, house fire, or cancer) over a large pool of people.  If you pay a little each month, you will be covered in the case of a disaster.

The core concept of insurance has not changed much in the last 400 years, and it won’t change in the future.  Technology and ‘big data’ only make calculating insurance risks easier.  The nature of insurance makes it one of the most stable industries in the world.

The stability of the insurance industry is fairly obvious.  The negative cost of capital aspect of insurance is less obvious.  Here’s how it works:

  1. The best insurers (like Aflac) make a profit on their insurance policies. They collect more in premium revenue than they pay in administration and benefits.
  2. Premium money that has yet to be paid out for claims is invested. This is called float.
  3. When you can acquire funds to invest for free or get paid to acquire those funds (like the better insurers do), you are effectively being given anegative interest rate loan that you can use to invest. In other words, you get a negative cost of capital.

You can see how negative interest rate loans – called insurance float – can be extremely powerful in the hands of a world class investor like Warren Buffett. Investing insurance float is how Buffett went from being a multi-millionaire to a multi-billionaire.

Page 1 of 3

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!